209 results
Page 5 of 11
424B5
0zp0xul
8 Nov 19
Prospectus supplement for primary offering
5:03pm
8-K
EX-1.1
xnkjpv6rij
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
424B5
ehu py6zssb9kj2p
6 Nov 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
fkav ghfm24
28 Oct 19
Agios Presents Data from Single Agent Dose-Escalation Arm of Phase 1 Study ofAG-270, a MAT2A Inhibitor, in Patients withMTAP-Deleted Tumors
7:20am
8-K
EX-99.1
5albnuqm
1 Aug 19
Agios Reports Business Highlights and Second Quarter 2019 Financial Results
7:29am
8-K
d6x1d hxd
16 Apr 19
Entry into a Material Definitive Agreement
4:06pm